San Francisco has taken a big step toward becoming the first major US city to require drug makers to fund and administer a citywide take-back program in which consumers can bring unused and unexpired medicines to drop-off destinations for disposal.
San Francisco has taken a big step toward becoming the first major US city to require drug makers to fund and administer a citywide take-back program in which consumers can bring unused and unexpired medicines to drop-off destinations for disposal. An ordinance was approved unanimously last week by the city’s Board of Supervisors and now awaits the signature of Mayor Edwin Lee, who has until Friday to sign the bill or it automatically becomes law.
The bill mimics a groundbreaking law passed 3 years ago by Alameda County, California, to establish a program over the protests of the pharmaceutical industry. Since then, drug makers have been concerned that other local governments will be emboldened to pass similar laws, raising their costs around the country.
Read more at The Wall Street Journal's Pharmalot blog: http://on.wsj.com/1BrZVV5
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More